This book provides a comprehensive review of the epidemiology, molecular pathogenesis, diagnosis and treatment of intrahepatic cholangiocarcinoma (ICC).  It brings together an impressive group of international experts in cholangiocarcinoma research and clinical care.  The book was organized and written to aid the clinicians understanding of emerging research in cholangiocarcinoma and its application to the clinical care of patients with ICC. Each chapter details the scientific evidence to support clinical decisions that are needed to care for these complex patients.  Focused chapters detail the epidemiology, diagnostic evaluation, as well as staging and prognosis of this disease. In addition to dedicated chapters on surgical management of ICC, a broad emphasis on locoregional therapies, including percutaneous ablation and transarterial therapies, is included. An up-to-date overview of the molecular pathogenesis and pathological assessment of ICC is detailed prior to chapters focusing on systemic chemotherapy and emerging novel therapy options.

Intrahepatic Cholangiocarcinoma is not only an invaluable resource for many as they seek to provide the best multidisciplinary cancer care to patients with ICC, but also an opportunity to identify new avenues of scientific discovery that lead to significant advances in the diagnosis and management of ICC.

Timothy M. Pawlik

The Ohio State University, Wexner Medical Center

Columbus, OH

USA

 

Jordan M. Cloyd

The Ohio State University, Wexner Medical Center

Columbus, OH

USA

 

Mary Dillhoff

The Ohio State University, Wexner Medical Center

Columbus, OH

USA

 

Epidemiology and Risk Factors.- Clinical Presentation and Diagnosis.- Staging and Prognosis.- Imaging.- Surgical Treatment.- Management of the Nodal Basin.- Pathologic Assessment.- Systemic Therapy.- Percutaneous Ablation.- Transarterial Therapies.- Radiotherapy.- Molecular Pathogenesis: From Inflammation And Cholestasis To A Microenvironment-Driven Tumor.- Clinical Trials and Novel/Emerging Treatment.